Synapse - Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis

Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis Meeting Abstract

Authors:	Bolton, K.; Ptashkin, R.; Braunstein, L.; Gao, T.; Devlin, S. M.; Kelly, D.; Coombs, C.; Patel, M.; Moarii, M.; Bernard, E.; Berthon, A.; Boucai, L.; Glodzik, D.; Martin, A.; Stadler, Z.; Walsh, M.; Mandelker, D.; Patel, A.; Schulman, J.; Gundem, G.; Syed, A.; Arcila, M.; Solit, D. B.; Robson, M. E.; Ladanyi, M.; Lee, C.; Philip, J.; Bajorin, D.; Garcia-Closas, M.; Gardos, S.; Hyman, D.; Tallman, M.; Yabe, M.; Offit, K.; Scher, H.; Klimek, V.; Diaz, L.; Chatterjee, N.; Berger, M. F.; Morton, L.; Levine, R.; Zehir, A.; Papaemmanuil, E.
Abstract Title:	Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
Meeting Title:	110th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title:	Cancer Research
Volume:	79
Issue:	13 Suppl.
Meeting Dates:	2019 Mar 29-Apr 3
Meeting Location:	Atlanta, GA
ISSN:	0008-5472
Publisher:	American Association for Cancer Research
Date Published:	2019-07-01
Language:	English
ACCESSION:	WOS:000488129901041
DOI:	10.1158/1538-7445.Am2019-lb-304
PROVIDER:	wos
Notes:	Meeting Abstract: LB-304 -- Source: Wos